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OndansetrOn and Meperidine prevent 
pOstOperative shivering after 
general anesthesia
Masoud EntEzari asl*, KhatErEh isazadEfar**,  
ali MohaMMadian*and ManouchEhr KhoshbatEn***
Abstract
Background: postoperative shivering is one of the common problems following general 
anesthesia and may lead to multiple complications. the aim of this study was to examine the 
preventive effects of Ondansetron and Meperidine on postoperative shivering.
Methods: this randomized placebo-controlled double blind clinical trial included 90 patients 
scheduled for elective gynecologic operations, randomly divided to three groups. Ondansetron 
(4mg), Meperidine (0.4 mg/kg) and 2 cc normal saline (as a control group) were administered 
immediately before the induction of anesthesia. anesthesia induced equivalently for all. patients 
were observed in terms of vital signs, side effects and shivering.
Results: postoperative shivering was observed in 13.3% of patients in Ondansetron group 
and 20% of Meperidine group, significantly lower than the controls (50%). The reduction of core 
and dermal temperature during the anesthesia and recovery, changes in systolic and diastolic blood 
pressure and heart rate were similar in all three groups. the incidence of nausea was similar among 
the three groups of study while vomiting occurred in 6.7% of the Meperidine group and 3.3% of 
the controls but none in the patients receiving Ondansetron.
Conclusion: Ondansetron can effectively reduce post operative shivering.
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Introduction
Shivering happens frequently after 5 to 60% of surgical operations1. though it occurs as 
a result of temperature reduction, it may occur in patients with a post-operative normal body 
temperature2. shivering may be dangerous due to increasing effect of medicines, extension of 
recovery period, increased oxygen consumption or hemostatic dysfunction especially in patients 
with a low cardiac reserve3. it may also result in hypoxemia4.
several medications have been suggested for the prevention and treatment of shivering. 
intravenous use of opioid drugs (pethidine, alfentanil, nalbuphine), non-opioid analgesics 
(tramadol), alpha-2-agonists (Clonidine), respiratory stimulators (doxapram) or physostigmine 
are reported to reduce or treat shivering5,6.
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according to regulator effect of intra-
hypothalamic serotonin (5-hydroxy tryptamine) its 
agonists (Ondansetron) are reported to have the same 
effect7. Contrary to pethidine, Ondansetron may 
reduce post operative nausea and vomiting (pOnv). 
a medication to reduce both pOnv and shivering will 
be very valuable. this study evaluated the preventive 
effect of Ondansetron and pethidine on post-operative 
shivering compared to a control group.
Patients and Methods
this study was carried out in alavi University 
clinic of ardebil during 2008. the protocol was 
approved by ethical committee of this University 
and included female patients undergoing elective 
gynecologic surgery during a 3 months period. 
all were in asa physiologic class i or ii. Obese 
patients (weight >100 kg), patients with fever (body 
temperature > 38°), endocrine problems or parkinson 
disease were excluded as well as patients who received 
blood, vasodilator or vasoconstrictor medications 
during the operation. long duration of the operation 
(>90 minutes) also resulted in exclusion.
patients then were randomly selected to receive 
either 4 mg Ondansetron, 0.4 mg/kg pethidine or 2cc 
normal saline (the placebo) 2 minutes before induction 
of anesthesia. the responsible anesthesiologist was 
blinded to the drug available in same 2 ml syringes.
anesthesia was induced by 1 µg/kg fentanyl, 
5 mg/kg thiopental and 1 mg/kg succinylcholine 
and maintained by 1-0.8% Isoflurane in an inspired 
mixture of 50% oxygen and 50% N2O after intubation. 
atracurium was administered to keep muscle 
relaxation. the patients were mechanically ventilated. 
room temperature was set at 20°-22 °C.
Body core and skin temperatures were measured 
through tympanic membrane and forehead accordingly. 
patients were observed for shivering (chills for at least 
15 seconds), nausea or vomiting during recovery by a 
technician blinded to the medication. patients received 
pethidine or metoclopramide when necessary.
all data were expressed as the mean ± sd. a chi-
squared test was used to compare qualitative variables. 
a repeated-measures anOva and Chi-square tests 
were used to compare the data before and after each 
treatment. A P value of 0.05 was considered statistically 
significant.
Results
thirty patients were studied in each group. no 
significant difference was found in terms of age and 
initial vital signs between the groups (table 1). as 
described in fig. 1 core body temperature decline 
in the controls was more than in patients receiving 
Ondansetron or pethidine but no significant difference 
was observed between Ondansetron and pethidine 
groups. decrease in the skin temperature was not 
different among three groups (fig. 2).
systolic and diastolic blood pressure was 
decreased in all patients during the surgery and came 
back up during recovery. heart rate increased after 
Table 1 
Initial vital signs as mean (SD)
Normal saline (n=30) Ondansetron (n=30) Pethidine (n=30) p
Age (years) 25.1 (4.2) 26.5 (6.1) 26.0 (5.8) 0.49
Duration of operation (minutes) 34.3 (7.4) 35.6 (7.5) 32.9 (6.1) 0.34
Core body temperature (° C) 37.5 (0.6) 37.5 (0.5) 37.4 (0.4) 0.76
Skin temperature (° C) 36.7 (0.8) 36.7 (0.6) 36.6 (0.5) 0.79
Systolic blood pressure (mmHg) 120.3 (16.1) 114.1 (20.3) 116.3 (16.7) 0.40
Diastolic blood pressure (mmHg) 76.6 (12.9) 73.1 (13.6) 78.3 (11.1) 0.25
Heart rate (beats/minute) 99.7 (16.4) 101.9 (19.2) 94.2 (19.4) 0.25
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induction of anesthesia and decreased slightly during 
the operation and recovery. No significant difference 
was noted among the three groups.
Shivering occurred significantly less in patients 
receiving Ondansetron or pethidine compared to the 
controls. results are shown in table 2.
Discussion
general anesthesia accelerates transmission 
of body core temperature to peripheral tissues and 
heat regulator mechanisms like the threshold for 
vasoconstriction became blocked8. The first phase of 
postoperative recovery is influenced by medications 
yet but along with decrease in their concentration, 
heat regulator mechanisms re-start functioning in the 
second phase where a body temperature lower than the 
set point will result in shivering9. Patients will benefit 
from fine management of shivering which will prevent 
sympathetic stimulation and excess oxygen use10.
the current study reports valuable preventive 
effect on shivering for Ondansetron and pethidine 
compared to controls compatible with some previous 
reports. Kelsaka et al reported a reduction in the 
occurrence of shivering after spinal anesthesia from 
36% (in controls) to 8% by either Ondansetron or 
pethidine4. Piper et al reported failure of 12.5 mg 
dolansetron to decrease this rate which was may be 
because of its inadequate dosage4,1. While powel et al 
reported shivering to occur in 57% of patients receiving 
saline compared to a rate of 33% followed by 4mg 
Ondansetron and 15% followed by 8 mg Ondansetron10. 
they highlighted the effect of Ondansetron to interfere 
with heat regulation by a central mechanism.
similar studies reported adverse effects for 
other medications. Clonidine may cause hypotension 
and drowsiness in addition to reducing shivering12. 
tramadol can reduce shivering but can decrease 
sweating and vasoconstriction as well13. doxapram 
as a brain stimulant prevents post operative shivering 
but has considerable hemodynamic side effects14. 
Physostigmine has significant preventive effects on 
shivering but increases heart rate and blood pressure 
and may be harmful in patients with coronary artery 
disease6. it is associated with nausea and vomiting as 
well. although pethidine has the minority effect on 
Fig. 2 
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Fig. 1 
Measured body core temperature in three groups
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Table 2 
Results of post operative observation in three groups
Normal saline (%) Ondansetron (%) Pethidine (%) p
Shivering 15 (50.0) 4 (13.3) 6 (20.0) 0.003
Nausea 3 (10.0) 3 (10.0) 3 (10.0) 1.00
Vomiting 2 (6.7) 0 1 (3.3) 0.30
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in conclusion using Ondansetron instead of 
pethidine is suggested because of its ability to reduce 
shivering from 50 to 13.3% in addition to less side 
effects especially in patients with hemodynamic 
instability.
cardiovascular system with the dosage used for treating 
shivering (0.3-0.4 mg/kg)15, it may extensively slow 
down respiration especially if used during the surgery. 
results of this study demonstrate the safety of using 
Ondansetron as well as its efficacy.
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